In silico and in vitro analysis of resistance genes in Klebsiella pneumoniae for assessing antibiotic efficacy and identifying novel therapeutic targets
Abstract
Urinary tract infections (UTIs) represent a major public health concern worldwide, with Klebsiella pneumoniae emerging as a prominent uropathogen due to its rapidly increasing multidrug resistance. This study aimed to evaluate the phenotypic and molecular resistance profiles of K. pneumoniae isolated from UTI patients and to identify potential therapeutic targets using integrated in vitro and in silico approaches. Urine samples were collected from clinically suspected UTI patients. Isolates were confirmed as K. pneumoniae through standard morphological and biochemical characterization. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method following Clinical and Laboratory Standards Institute (CLSI) guidelines. Molecular detection of resistance genes was carried out by polymerase chain reaction (PCR), while computational analyses including molecular docking, molecular dynamics simulations and ADMET profiling, were employed to evaluate potential drug candidates. Phenotypic analysis revealed high resistance rates to ampicillin, amoxicillin-clavulanate, cotrimoxazole, ciprofloxacin, and ceftriaxone, indicating a substantial prevalence of multidrug-resistant strains. Reduced susceptibility was observed against gentamicin, nitrofurantoin, fosfomycin, and imipenem, with emerging carbapenem resistance noted among the isolates. Molecular investigations identified the blaTEM gene as the most prevalent resistance determinant, strongly associated…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.